National Cancer Waiting Times Monitoring Data Set Scenarios
National Cancer Waiting Times Monitoring Data Set: Concept of Operation and Patient Pathway Scenarios.
Description
National Cancer Waiting Times Monitoring Data Set: Concept of Operation and Patient Pathway Scenarios.
The National Cancer Waiting Times Monitoring Data Set is a generic data set designed to support the monitoring of waiting times for a variety of different pathways of cancer care. For the purpose of this data collection cancer is defined using the International Classification of Diseases (ICD) codes. The full list of International Classification of Diseases (ICD) diagnosis codes is available on the NHS England website at: Cancer Waiting Times.
Collection and submission of the National Cancer Waiting Times Monitoring Data Set is to be managed according to the maximum waiting time and information requirements of the pathway of care for each individual PATIENT. These requirements for providers of cancer SERVICES to return data to the Cancer Waiting Times Database are defined using different scenarios.
-
Scenario 1a:
The Health Care Provider where the PATIENT is first seen following a REFERRAL REQUEST with PRIORITY TYPE 'Two Week Wait', or where an urgent referral is from an NHS Cancer Screening Programme, and where the PATIENT has not had a Decision To Treat, has not had the diagnosis outcome communicated, and the PATIENT has not been excluded from the Cancer Faster Diagnosis Pathway. No inter-provider transfers are in progress.
-
Scenario 1b:
The Health Care Provider where the PATIENT is first seen following a REFERRAL REQUEST with PRIORITY TYPE 'Two Week Wait', or where an urgent referral is from an NHS Cancer Screening Programme, and where the PATIENT has not had a Decision To Treat, has had the diagnosis outcome communicated, and the PATIENT has not been excluded from the Cancer Faster Diagnosis Pathway. No inter-provider transfers are in progress.
-
Scenario 1c:
The Health Care Provider where the PATIENT is first seen following a direct access diagnostic test result that suggested an urgent suspected cancer referral with PRIORITY TYPE 'Two Week Wait' was required, and where a locally agreed escalation process to secondary care has been followed (as defined in National Cancer Waiting Times Monitoring Data Set - A Guide), where the PATIENT has not had the Decision To Treat, and has not had the diagnosis outcome communicated, and the PATIENT has not been excluded from the Cancer Faster Diagnosis Pathway. No inter provider transfers are in progress.
-
Scenario 1d:
The Health Care Provider where the PATIENT is first seen following a REFERRAL REQUEST with PRIORITY TYPE 'Two Week Wait', or where an urgent referral is from an NHS Cancer Screening Programme, and where the PATIENT has had the Decision To Treat, has had the diagnosis outcome communicated, and the PATIENT has not been excluded from the Cancer Faster Diagnosis Pathway. No inter-provider transfers are in progress.
-
Scenario 1e:
The Health Care Provider where the PATIENT is first seen following a REFERRAL REQUEST with PRIORITY TYPE 'Two Week Wait', or where an urgent referral is from an NHS Cancer Screening Programme, and where the PATIENT has not had a Decision To Treat, has not had the diagnosis outcome communicated, and the PATIENT has not been excluded from the Cancer Faster Diagnosis Pathway. The Health Care Provider sends the PATIENT to another Health Care Provider, that is, makes an inter-provider transfer.
-
Scenario 1f:
The Health Care Provider receiving an inter-provider transfer of a PATIENT, where the PATIENT is first seen at a different Health Care Provider, and where the PATIENT has not had a Decision To Treat, has not had the diagnosis outcome communicated, and the PATIENT has not been excluded from the Cancer Faster Diagnosis Pathway. The Health Care Provider then subsequently sends the PATIENT to another Health Care Provider, that is, makes a further inter-provider transfer.
-
Scenario 1g:
The Health Care Provider where the PATIENT is first seen following a REFERRAL REQUEST with PRIORITY TYPE 'Two Week Wait', or where an urgent referral is from an NHS Cancer Screening Programme, and where the PATIENT has not had a Decision To Treat, has not had the diagnosis outcome communicated, and the PATIENT has been excluded from the Cancer Faster Diagnosis Pathway. No inter-provider transfers are in progress.
-
Scenario 2a:
The Health Care Provider where the PATIENT receives First Definitive Treatment for cancer following a REFERRAL REQUEST with PRIORITY TYPE 'Two Week Wait', or where an urgent referral is from an NHS Cancer Screening Programme, and where the PATIENT has had the Decision To Treat, has had the diagnosis outcome communicated, and the PATIENT has not been excluded from the Cancer Faster Diagnosis Pathway. No inter-provider transfers are in progress.
-
Scenario 2b:
The Health Care Provider where the PATIENT receives First Definitive Treatment for cancer following an inter-provider transfer, and where the PATIENT has had the Decision To Treat, and has had the diagnosis outcome communicated, and the PATIENT has not been excluded from the Cancer Faster Diagnosis Pathway.
-
Scenario 3:
The Health Care Provider where the PATIENT receives second or subsequent treatment for cancer following a REFERRAL REQUEST with PRIORITY TYPE 'Two Week Wait', or where an urgent referral is from an NHS Cancer Screening Programme. No inter-provider transfers are in progress.
-
Scenario 4:
The Health Care Provider where the PATIENT receives First Definitive Treatment for cancer following a consultant upgrade onto a 62 day PATIENT PATHWAY. No inter-provider transfers are in progress.
-
Scenario 5:
The Health Care Provider where the PATIENT receives second or subsequent treatment for cancer following a consultant upgrade onto a 62 day PATIENT PATHWAY. No inter-provider transfers are in progress.
-
Scenario 6:
The Health Care Provider where the PATIENT receives First Definitive Treatment for cancer following a REFERRAL REQUEST from another SOURCE OF REFERRAL FOR OUT-PATIENTS or a different PRIORITY TYPE. No inter-provider transfers are in progress.
-
Scenario 7:
The Health Care Provider where the PATIENT receives second or subsequent treatment for cancer following a REFERRAL REQUEST from another SOURCE OF REFERRAL FOR OUT-PATIENTS or a different PRIORITY TYPE. No inter-provider transfers are in progress.
The columns in the table below show which data items are required for a range of health care scenarios:
Data Set Notation:
-
M = Mandatory:
the Standard Contract Schedule 5 requires NHS provider ORGANISATIONS to submit this information on a monthly basis. NHS England require the data to be submitted a number of working days after the end of each month or quarter. This submission schedule is set out on the NHS England website at: Cancer Waiting Times Data Collection (CWT).
-
M* = Mandatory if applicable:
the Standard Contract Schedule 5 requires NHS provider ORGANISATIONS to submit this information on a monthly basis, where collection of the item was applicable to them. NHS England require the data to be submitted a number of working days after the end of each month or quarter. This submission schedule is set out on the NHS England website at: Cancer Waiting Times Data Collection (CWT).
- O = Optional
-
O* = Optional if applicable:
These optional fields should only be populated if they relate to the PATIENT PATHWAY identified in the scenarios and the conditions required for their use are met.
- N/A = Not Applicable
Note: Inter-Provider Transfers:
-
# First transfer involving the Health Care Provider
-
## Second transfer involving the Health Care Provider. There can be up to ten inter-provider transfers involving many ORGANISATIONS, but an individual ORGANISATION can only be involved in two transfers of a PATIENT.
Data Item |
Scenario 1a |
Scenario 1b |
Scenario 1c |
Scenario 1d |
Scenario 1e |
Scenario 1f |
Scenario 1g |
Scenario 2a |
Scenario 2b |
Scenario 3 |
Scenario 4 |
Scenario 5 |
Scenario 6 |
Scenario 7 |
NHS NUMBER |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
NHS NUMBER STATUS INDICATOR CODE |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
PATIENT PATHWAY IDENTIFIER |
M |
M |
M |
M |
M |
M |
M |
M* |
M* |
M* |
M* |
M* |
M* |
M* |
ORGANISATION IDENTIFIER (PATIENT PATHWAY IDENTIFIER ISSUER) |
M |
M |
M |
M |
M |
M |
M |
M* |
M* |
M* |
M* |
M* |
M* |
M* |
SOURCE OF REFERRAL FOR OUT-PATIENTS |
M |
M |
M |
M |
M |
N/A |
M |
N/A |
N/A |
N/A |
M |
N/A |
O |
N/A |
PRIORITY TYPE CODE |
M |
M |
M |
M |
M |
N/A |
M |
N/A |
N/A |
N/A |
M |
N/A |
O |
N/A |
DECISION TO REFER DATE (CANCER OR BREAST SYMPTOMS) |
M* |
M* |
M* |
M* |
M* |
N/A |
M* |
N/A |
N/A |
N/A |
N/A |
N/A |
O |
N/A |
CANCER REFERRAL TO TREATMENT PERIOD START DATE |
M |
M |
M |
M |
M |
N/A |
M |
M |
N/A |
N/A |
O |
N/A |
O |
N/A |
TWO WEEK WAIT CANCER OR SYMPTOMATIC BREAST REFERRAL TYPE |
M |
M |
M |
M |
M |
N/A |
M |
N/A |
N/A |
N/A |
N/A |
N/A |
O |
N/A |
CONSULTANT UPGRADE DATE |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
N/A |
O |
N/A |
ORGANISATION SITE IDENTIFIER (OF PROVIDER CONSULTANT UPGRADE) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
N/A |
O |
N/A |
DATE FIRST SEEN |
M |
M |
M |
M |
M |
N/A |
M |
N/A |
N/A |
N/A |
M |
N/A |
O |
N/A |
ORGANISATION SITE IDENTIFIER (OF PROVIDER FIRST SEEN) |
M |
M |
M |
M |
M |
N/A |
M |
N/A |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
WAITING TIME ADJUSTMENT (FIRST SEEN) |
M* |
M* |
M* |
M* |
M* |
N/A |
M* |
N/A |
N/A |
N/A |
O* |
N/A |
N/A |
N/A |
WAITING TIME ADJUSTMENT REASON (FIRST SEEN) |
M* |
M* |
M* |
M* |
M* |
N/A |
M* |
N/A |
N/A |
N/A |
O* |
N/A |
N/A |
N/A |
CANCER CARE SPELL DELAY REASON (FIRST SEEN) |
M* |
M* |
M* |
M* |
M* |
N/A |
M* |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
CANCER CARE SPELL DELAY REASON COMMENT (FIRST SEEN) |
O* |
O* |
O* |
O* |
O* |
N/A |
O* |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
CANCER DIAGNOSTIC REFERRAL ROUTE |
O* |
O* |
M* |
O* |
O* |
N/A |
O* |
O* |
N/A |
N/A |
N/A |
N/A |
O* |
N/A |
RAPID DIAGNOSTIC CENTRE PATHWAY COMPLIANCE INDICATOR |
O* |
O* |
O* |
O* |
O* |
N/A |
O* |
O* |
N/A |
N/A |
N/A |
N/A |
O* |
N/A |
CANCER OR SYMPTOMATIC BREAST REFERRAL PATIENT STATUS |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
M |
PRIMARY DIAGNOSIS (ICD) |
N/A |
M* |
N/A |
M* |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
TUMOUR LATERALITY |
N/A |
M* |
N/A |
M* |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
CANCER TREATMENT PERIOD START DATE |
N/A |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
ORGANISATION SITE IDENTIFIER (OF PROVIDER CANCER DECISION TO TREAT) |
N/A |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
REFERRAL REQUEST RECEIVED DATE (INTER-PROVIDER TRANSFER)
# |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
N/A |
N/A |
PROSTATE CANCER CLINICAL RISK CATEGORY |
M* |
M* |
M* |
M* |
M* |
N/A |
M* |
M* |
M* |
M* |
M* |
M* |
M* |
M* |
CANCER FASTER DIAGNOSIS PATHWAY END REASON |
N/A |
M |
N/A |
M |
N/A |
N/A |
M |
M |
M |
M* |
N/A |
N/A |
N/A |
N/A |
PRIMARY CANCER SITE (CANCER FASTER DIAGNOSIS PATHWAY) |
N/A |
M |
N/A |
M |
N/A |
N/A |
N/A |
M |
M |
N/A |
N/A |
N/A |
N/A |
N/A |
CANCER FASTER DIAGNOSIS PATHWAY END DATE |
N/A |
M |
N/A |
M |
N/A |
N/A |
M |
M |
M |
M* |
N/A |
N/A |
N/A |
N/A |
CANCER CARE SPELL DELAY REASON (OUTCOME COMMUNICATION CANCER FASTER DIAGNOSIS PATHWAY) |
N/A |
M* |
N/A |
M* |
N/A |
N/A |
N/A |
M* |
M* |
N/A |
N/A |
N/A |
N/A |
N/A |
CANCER CARE SPELL DELAY REASON COMMENT (OUTCOME COMMUNICATION CANCER FASTER DIAGNOSIS PATHWAY) |
N/A |
O* |
N/A |
O* |
N/A |
N/A |
N/A |
O* |
O* |
N/A |
N/A |
N/A |
N/A |
N/A |
CANCER FASTER DIAGNOSIS PATHWAY EXCLUSION REASON |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
N/A |
N/A |
M* |
N/A |
N/A |
N/A |
N/A |
CARE PROFESSIONAL TYPE (OUTCOME COMMUNICATION CANCER FASTER DIAGNOSIS PATHWAY) |
N/A |
O* |
N/A |
O* |
N/A |
N/A |
N/A |
O* |
O* |
N/A |
N/A |
N/A |
N/A |
N/A |
METHOD OF COMMUNICATION (END OF CANCER FASTER DIAGNOSIS PATHWAY) |
N/A |
O* |
N/A |
O* |
N/A |
N/A |
N/A |
O* |
O* |
N/A |
N/A |
N/A |
N/A |
N/A |
ORGANISATION SITE IDENTIFIER (OF CANCER FASTER DIAGNOSIS PATHWAY END DATE) |
N/A |
M |
N/A |
M |
N/A |
N/A |
M |
M |
M |
M* |
N/A |
N/A |
N/A |
N/A |
SERVICE REQUESTED DATE (INTER-PROVIDER TRANSFER)
# |
N/A |
N/A |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
ORGANISATION IDENTIFIER (REFERRING)
# |
N/A |
N/A |
N/A |
N/A |
M |
M |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
N/A |
N/A |
ORGANISATION IDENTIFIER (RECEIVING)
# |
N/A |
N/A |
N/A |
N/A |
M |
M |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
N/A |
N/A |
CANCER TRANSFER REFERRING REASON (INTER-PROVIDER TRANSFER)
# |
N/A |
N/A |
N/A |
N/A |
O |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
CANCER TRANSFER RECEIVING REASON (INTER-PROVIDER TRANSFER)
# |
N/A |
N/A |
N/A |
N/A |
N/A |
O |
N/A |
N/A |
O |
N/A |
N/A |
N/A |
N/A |
N/A |
REFERRAL REQUEST RECEIVED DATE (INTER-PROVIDER TRANSFER)
## |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
SERVICE REQUESTED DATE (INTER-PROVIDER TRANSFER)
## |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
ORGANISATION IDENTIFIER (REFERRING)
## |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
ORGANISATION IDENTIFIER (RECEIVING)
## |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
CANCER TRANSFER REFERRING REASON (INTER-PROVIDER TRANSFER)
## |
N/A |
N/A |
N/A |
N/A |
N/A |
O |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
CANCER TRANSFER RECEIVING REASON (INTER-PROVIDER TRANSFER)
## |
N/A |
N/A |
N/A |
N/A |
N/A |
O |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
TREATMENT START DATE (CANCER) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
ORGANISATION SITE IDENTIFIER (OF PROVIDER CANCER TREATMENT START DATE) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
CANCER TREATMENT EVENT TYPE |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
CANCER TREATMENT MODALITY |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
CLINICAL TRIAL INDICATOR |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
CANCER CARE SETTING (TREATMENT) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M |
M |
M |
M |
M |
M |
M |
CANCER CARE SPELL DELAY REASON (DECISION TO TREATMENT) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M* |
M* |
M* |
M* |
M* |
M* |
M* |
CANCER CARE SPELL DELAY REASON COMMENT (DECISION TO TREATMENT) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
O* |
O* |
O* |
O* |
O* |
O* |
O* |
WAITING TIME ADJUSTMENT (TREATMENT) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M* |
M* |
M* |
M* |
M* |
M* |
M* |
WAITING TIME ADJUSTMENT REASON (TREATMENT) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M* |
M* |
M* |
M* |
M* |
M* |
M* |
CANCER CARE SPELL DELAY REASON (REFERRAL TO TREATMENT) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M* |
M* |
N/A |
M* |
N/A |
O* |
N/A |
CANCER CARE SPELL DELAY REASON COMMENT (REFERRAL TO TREATMENT) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
O* |
O* |
N/A |
O* |
O* |
O* |
N/A |
CANCER CARE SPELL DELAY REASON (CONSULTANT UPGRADE) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
M* |
N/A |
O* |
N/A |
CANCER CARE SPELL DELAY REASON COMMENT (CONSULTANT UPGRADE) |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
O* |
N/A |
O* |
N/A |
Full details of the validation rules and processes are available on the NHS England website at: Cancer Waiting Times.
Also Known As
This Supporting information is also known by these names:
Context | Alias |
---|---|
Full name | National Cancer Waiting Times Monitoring Data Set: Scenarios |
Short name | Patient Pathway Scenarios |
Where Used
Type | Link | How used |
---|---|---|
Data Set | National Cancer Waiting Times Monitoring Data Set | references in description National Cancer Waiting Times Monitoring Data Set Scenarios |